Skip to Main Content

Paper Details

Genetic Alterations Detected in Cell-Free DNA Are Associated With Enzalutamide and Abiraterone Resistance in Castration-Resistant Prostate Cancer.
JCO Precis Oncol
39
2019
AR, AR CN, AR gene, AR ligand, Androgen, Androgen receptor, Androgen receptor (AR) gene, Castration-Resistant Prostate Cancer, Cell-Free DNA, Enzalutamide, Patients, Tumor protein p53, abiraterone, cancer, cancer-associated genes, cell, cell-free DNA, cfDNA, circulating, circulating tumor DNA, enzalutamide, mCRPC, men, metastatic castration-resistant prostate cancer, patients, phosphoinositide 3-kinase, prostate-specific antigen, tumor, tumor DNA, tumor protein p53
Author NameAffiliation
Aparna PallavajjalaJohns Hopkins School of Medicine
Brian W SimonsJohns Hopkins School of Medicine
Michael A CarducciJohns Hopkins School of Medicine
Channing J PallerJohns Hopkins School of Medicine
Mario A EisenbergerJohns Hopkins School of Medicine
Emmanuel S AntonarakisJohns Hopkins School of Medicine
Bruce J TrockJohns Hopkins School of Medicine
Ben Ho ParkJohns Hopkins School of Medicine
Ben Ho ParkJohns Hopkins University
Ben Ho ParkJohns Hopkins School of Medicine
Ben Ho ParkJohns Hopkins University
  • 1 - 11

Datasets

Release 1.2